The miR-217 inhibits in vitro tumor cell growth and it functions as a potential tumor-suppressor by influencing the Akt/KRAS signaling pathway, therefore, miR-217 is frequently down-regulated in PDAC. Here, AKT1 is linked to neoplasm.